1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral 1.2.3 Parenteral (Subcutaneous Injection) 1.3 Market by Application 1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Drug Store 1.3.3 Independent Pharmacies 1.3.4 Hospital Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2016-2027) 2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Regions 2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Opioid-Induced Constipation (OIC) Treatment Industry Dynamic 2.3.1 Opioid-Induced Constipation (OIC) Treatment Market Trends 2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers 2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges 2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue 3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2016-2021) 3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue 3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio 3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020 3.5 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served 3.6 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service 3.7 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type 4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2016-2021) 4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027) 5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application 5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2016-2021) 5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027) 6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type 6.2.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) 6.2.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) 6.2.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027) 6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application 6.3.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) 6.3.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) 6.3.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027) 6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country 6.4.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) 6.4.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027) 7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type 7.2.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) 7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) 7.2.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027) 7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application 7.3.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) 7.3.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) 7.3.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027) 7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country 7.4.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) 7.4.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027) 8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type 8.2.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application 8.3.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region 8.4.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027) 9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type 9.2.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027) 9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application 9.3.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027) 9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country 9.4.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027) 10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type 10.2.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application 10.3.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country 10.4.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction 11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.1.5 GlaxoSmithKline Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction 11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.2.5 AstraZeneca Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction 11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 S.L.A. Pharma 11.4.1 S.L.A. Pharma Company Details 11.4.2 S.L.A. Pharma Business Overview 11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction 11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.4.5 S.L.A. Pharma Recent Development 11.5 AIKO Biotechnology 11.5.1 AIKO Biotechnology Company Details 11.5.2 AIKO Biotechnology Business Overview 11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction 11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.5.5 AIKO Biotechnology Recent Development 11.6 Cubist Pharmaceuticals 11.6.1 Cubist Pharmaceuticals Company Details 11.6.2 Cubist Pharmaceuticals Business Overview 11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction 11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.6.5 Cubist Pharmaceuticals Recent Development 11.7 Salix Pharmaceuticals 11.7.1 Salix Pharmaceuticals Company Details 11.7.2 Salix Pharmaceuticals Business Overview 11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction 11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.7.5 Salix Pharmaceuticals Recent Development 11.8 Takeda Pharmaceutical 11.8.1 Takeda Pharmaceutical Company Details 11.8.2 Takeda Pharmaceutical Business Overview 11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction 11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) 11.8.5 Takeda Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oral Table 3. Key Players of Parenteral (Subcutaneous Injection) Table 4. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2016-2021) Table 8. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027) Table 10. Opioid-Induced Constipation (OIC) Treatment Market Trends Table 11. Opioid-Induced Constipation (OIC) Treatment Market Drivers Table 12. Opioid-Induced Constipation (OIC) Treatment Market Challenges Table 13. Opioid-Induced Constipation (OIC) Treatment Market Restraints Table 14. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players (2016-2021) Table 16. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020) Table 17. Ranking of Global Top Opioid-Induced Constipation (OIC) Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service Table 21. Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. GlaxoSmithKline Company Details Table 62. GlaxoSmithKline Business Overview Table 63. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product Table 64. GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 65. GlaxoSmithKline Recent Development Table 66. AstraZeneca Company Details Table 67. AstraZeneca Business Overview Table 68. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product Table 69. AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 70. AstraZeneca Recent Development Table 71. Pfizer Company Details Table 72. Pfizer Business Overview Table 73. Pfizer Opioid-Induced Constipation (OIC) Treatment Product Table 74. Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 75. Pfizer Recent Development Table 76. S.L.A. Pharma Company Details Table 77. S.L.A. Pharma Business Overview Table 78. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product Table 79. S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 80. S.L.A. Pharma Recent Development Table 81. AIKO Biotechnology Company Details Table 82. AIKO Biotechnology Business Overview Table 83. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product Table 84. AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 85. AIKO Biotechnology Recent Development Table 86. Cubist Pharmaceuticals Company Details Table 87. Cubist Pharmaceuticals Business Overview Table 88. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Table 89. Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 90. Cubist Pharmaceuticals Recent Development Table 91. Salix Pharmaceuticals Company Details Table 92. Salix Pharmaceuticals Business Overview Table 93. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Table 94. Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 95. Salix Pharmaceuticals Recent Development Table 96. Takeda Pharmaceutical Company Details Table 97. Takeda Pharmaceutical Business Overview Table 98. Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million) Table 99. Takeda Pharmaceutical Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Type: 2020 VS 2027 Figure 2. Oral Features Figure 3. Parenteral (Subcutaneous Injection) Features Figure 4. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2020 VS 2027 Figure 5. Drug Store Case Studies Figure 6. Independent Pharmacies Case Studies Figure 7. Hospital Pharmacies Case Studies Figure 8. Opioid-Induced Constipation (OIC) Treatment Report Years Considered Figure 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027) Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players in 2020 Figure 14. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020 Figure 16. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027) Figure 20. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027) Figure 21. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027) Figure 22. United States Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027) Figure 26. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027) Figure 27. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027) Figure 28. Germany Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2016-2027) Figure 38. China Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027) Figure 46. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027) Figure 47. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027) Figure 48. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027) Figure 54. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. GlaxoSmithKline Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 58. AstraZeneca Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 60. S.L.A. Pharma Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 61. AIKO Biotechnology Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 62. Cubist Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 63. Salix Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

GlaxoSmithKline AstraZeneca Pfizer S.L.A. Pharma AIKO Biotechnology Cubist Pharmaceuticals Salix Pharmaceuticals Takeda Pharmaceutical